0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 emea europe middle east africa non small cell lung cancer therapeutics market report 2018.Your search for "" gave back 1533064 results.
Non-Small Cell Lung Cancer (NSCLC) is the most common cancer and the leading cause of cancer-related mortality globally. In the context of China-US...
Catalog:
9Dimen Research
September 2020
Price: USD 2,850.00
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Lung Cancer Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct...
Catalog:
Global Markets Direct
December 2022
Price: USD 2,500.00
Summary Non-small Cell Lung Cancer market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
March 2019
Price: USD 2,960.00
Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021 Summary Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,500.00
Summary Non-small Cell Lung Cancer market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
March 2021
Price: USD 2,960.00
Summary Non-small Cell Lung Cancer market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
March 2020
Price: USD 2,960.00
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2018 Summary Cytotoxic T...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Squamous Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Squamous Non-Small Cell...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,500.00
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or...
Catalog:
Global Markets Direct
July 2018
Price: USD 3,500.00
Small-Cell Lung Cancer - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
